Detailed price information for Dare Bioscience Inc (DARE-Q) from The Globe and Mail including charting and trades.

Dare´ Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science ...

On 20 February this year, your Board announced that the Company had, subject to shareholder approval, agreed a proposed combination of assets (the “Combination”) with BlackRock Smaller Companies Trust ...

Atrial fibrillation (AF), the most common chronic cardiac arrhythmia in clinical practice, is very challenging to treat once it becomes persistent, after which spontaneous return to normal rhythm ...

Atrial fibrillation (AF), the most common chronic cardiac arrhythmia in clinical practice, is very challenging to treat once it becomes persistent, after which spontaneous return to normal rhythm ...

The Arab region is experiencing a gradual economic recovery, with regional growth projected to reach 3.7% this year, a new ...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for the treatment of chronic cough in patients ...

New York-based Sweetwater Labs has built a customer base around 100% natural skincare formulations developed through ...

Matador has recently expanded its global footprint by investing in HODL Systems, one of India’s first digital asset treasury ...

HNI (NYSE:HNI) executives highlighted what they called a “seminal year” in fiscal 2025, pointing to a fourth consecutive year ...

Background Gut microbiota dysbiosis is linked to autism spectrum disorder (ASD) in children. However, the role of bacterial ...

Background and objective Speech disorders are a common presenting concern to paediatricians. Yet evidence to guide detection and speech sound therapy referral of cases at risk for persistent speech ...